These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 29080413

  • 1. A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent.
    Naicker S, Guerra Valero YC, Ordenez Meija JL, Lipman J, Roberts JA, Wallis SC, Parker SL.
    J Pharm Biomed Anal; 2018 Jan 30; 148():324-333. PubMed ID: 29080413
    [Abstract] [Full Text] [Related]

  • 2. High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.
    Augey V, Grosse PY, Albert G, Audran M, Bressolle F.
    J Chromatogr B Biomed Appl; 1996 Jun 28; 682(1):125-36. PubMed ID: 8832433
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
    Varghese JM, Jarrett P, Boots RJ, Kirkpatrick CM, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2014 Apr 28; 43(4):343-8. PubMed ID: 24612982
    [Abstract] [Full Text] [Related]

  • 4. A rapid, LC-MS/MS assay for quantification of piperacillin and tazobactam in human plasma and pleural fluid; application to a clinical pharmacokinetic study.
    Popowicz ND, O'Halloran SJ, Fitzgerald D, Lee YCG, Joyce DA.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr 01; 1081-1082():58-66. PubMed ID: 29505960
    [Abstract] [Full Text] [Related]

  • 5. Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation.
    D'Cunha R, Bach T, Young BA, Li P, Nalbant D, Zhang J, Winokur P, An G.
    Antimicrob Agents Chemother; 2018 Sep 01; 62(9):. PubMed ID: 29941654
    [Abstract] [Full Text] [Related]

  • 6. A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane-tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies.
    Parker SL, Pandey S, Sime FB, Stuart J, Lipman J, Roberts JA, Wallis SC.
    Clin Chem Lab Med; 2021 Apr 27; 59(5):921-933. PubMed ID: 33554515
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin.
    Di Giovamberardino G, Ferrannini M, Testore GP, Federici G, Pastore A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan 01; 877(1-2):86-8. PubMed ID: 19058767
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography.
    Ocampo AP, Hoyt KD, Wadgaonkar N, Carver AH, Puglisi CV.
    J Chromatogr; 1989 Nov 10; 496(1):167-79. PubMed ID: 2556418
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.
    Awissi DK, Beauchamp A, Hébert E, Lavigne V, Munoz DL, Lebrun G, Savoie M, Fagnan M, Amyot J, Tétreault N, Robitaille R, Varin F, Lavallée C, Pichette V, Leblanc M.
    Pharmacotherapy; 2015 Jun 10; 35(6):600-7. PubMed ID: 26095008
    [Abstract] [Full Text] [Related]

  • 14. An Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and Linezolid in Human Plasma Samples.
    Piestansky J, Cizmarova I, Mikus P, Parrak V, Babiak P, Secnik P, Secnik P, Kovac A.
    Ther Drug Monit; 2022 Dec 01; 44(6):784-790. PubMed ID: 35971670
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.
    Bauer SR, Salem C, Connor MJ, Groszek J, Taylor ME, Wei P, Tolwani AJ, Fissell WH.
    Clin J Am Soc Nephrol; 2012 Mar 01; 7(3):452-7. PubMed ID: 22282479
    [Abstract] [Full Text] [Related]

  • 16. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
    Roger C, Cotta MO, Muller L, Wallis SC, Lipman J, Lefrant JY, Roberts JA.
    Int J Antimicrob Agents; 2017 Aug 01; 50(2):227-231. PubMed ID: 28689876
    [Abstract] [Full Text] [Related]

  • 17. Preanalytical Stability of Piperacillin, Tazobactam, Meropenem, and Ceftazidime in Plasma and Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry.
    Mortensen JS, Jensen BP, Zhang M, Doogue M.
    Ther Drug Monit; 2019 Aug 01; 41(4):538-543. PubMed ID: 31306394
    [Abstract] [Full Text] [Related]

  • 18. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA, Smith MN, Painter JT, Meena NK, Lusardi K.
    Pharmacotherapy; 2016 May 01; 36(5):463-71. PubMed ID: 26952639
    [Abstract] [Full Text] [Related]

  • 19. Population pharmacokinetics of piperacillin/tazobactam in critically ill young children.
    Cies JJ, Shankar V, Schlichting C, Kuti JL.
    Pediatr Infect Dis J; 2014 Feb 01; 33(2):168-73. PubMed ID: 23907263
    [Abstract] [Full Text] [Related]

  • 20. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, Lipman J, Bellomo R, RENAL Replacement Therapy Study Investigators.
    Crit Care Med; 2012 May 01; 40(5):1523-8. PubMed ID: 22511133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.